Historical return extremes for Bristol-Myers Squibb (BMY) from 1972 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +44,954% | $0.16 | $70.19 | $450,542.40 | ||
| Max drawdownMore info about Max drawdown | -70.61% | $28.24 | $8.30 | $293.91 | ||
| Return since IPOMore info about Return since IPO | +19,080% | $0.29 | $56.24 | $191,801.38 |
- Max profitMore info about Max profit+44,954%$450,542.40
- Max drawdownMore info about Max drawdown-70.61%$293.91
- Return since IPOMore info about Return since IPO+19,080%$191,801.38
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Bristol-Myers Squibb (BMY). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement